Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCORE long-term routine clinical practice study of subcutaneous abatacept in rheumatoid arthritis
NL-OMON24848Recruiting
- Sponsor
- Bristol-Myers Squibb B.V. Vijzelmolenlaan 9 3447 GX Woerden Telefoon: 0348-574222 Telefax: 0348-423084
- Start
- Jun 2013
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of abatacept in rheumatoid arthritis (RA) (2 cohorts), sponsored by Bristol-Myers Squibb B.V. Vijzelmolenlaan 9 3447 GX Woerden Telefoon: 0348-574222 Telefax: 0348-423084. Primary endpoints: Abatacept SC retention rate over 24 months, Prescribing patterns of abatacept SC and 2 more. Started Jun 2013; status: recruiting.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON24848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24848.